WKWenzel Kaltenbacher

Wenzel Kaltenbacher

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wenzel Kaltenbacher has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Alina Semenjakin

    Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg—Bad Krozingen and Faculty of Medicine, Albert-Ludwig University of Freiburg, 79110 Freiburg im Breisgau, Germany

    2 shared publications
  • Dominik J. Fiegle

    Institute of Cellular and Molecular Physiology, Friedrich-Alexander-University of Erlangen-Nürnberg, 91054 Erlangen, Germany

    2 shared publications
  • Eva Alicja Rog-Zielinska

    Institute for Experimental Cardiovascular Medicine University Heart Center Freiburg · Bad Krozingen, University of Freiburg Freiburg Germany

    2 shared publications
  • Joachim Greiner

    Institute for Experimental Cardiovascular Medicine, University Heart Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany

    2 shared publications
  • Marica Dente

    Department of Experimental and Clinical Medicine, Division of Physiology, University of Florence, 50134 Florence, Italy

    2 shared publications
  • Peter Kohl

    Institute for Experimental Cardiovascular Medicine University Heart Center Freiburg ‒ Bad Krozingen, Medical Faculty and Medical Center – University of Freiburg Freiburg im Breisgau Germany

    2 shared publications

Latest Publications

  • Open Access

    Correction: Greiner et al. Consecutive-Day Ventricular and Atrial Cardiomyocyte Isolations from the Same Heart: Shifting the Cost–Benefit Balance of Cardiac Primary Cell Research. Cells 2022, 11, 233

    by Joachim Greiner, Teresa Schiatti, Wenzel Kaltenbacher, Marica Dente, Alina Semenjakin, Thomas Kok, Dominik J. Fiegle, Thomas Seidel, Ursula Ravens, Peter Kohl, et al.

  • Open Access

    Consecutive-Day Ventricular and Atrial Cardiomyocyte Isolations from the Same Heart: Shifting the Cost–Benefit Balance of Cardiac Primary Cell Research

    by Joachim Greiner, Teresa Schiatti, Wenzel Kaltenbacher, Marica Dente, Alina Semenjakin, Thomas Kok, Dominik J. Fiegle, Thomas Seidel, Ursula Ravens, Peter Kohl, et al.

    Freshly isolated primary cardiomyocytes (CM) are indispensable for cardiac research. Experimental CM research is generally incompatible with life of the donor animal, while human heart samples are usually small and scarce. CM isolation from animal hearts, traditionally performed by coronary artery perfusion of enzymes, liberates millions of cells from the heart. However, due to progressive cell remodeling following isolation, freshly isolated primary CM need to be used within 4–8 h post-isolation for most functional assays, meaning that the majority of cells is essentially wasted. In addition, coronary perfusion-based isolation cannot easily be applied to human tissue biopsies, and it does not straightforwardly allow for assessment of regional differences in CM function within the same heart. Here, we provide a method of multi-day CM isolation from one animal heart, yielding calcium-tolerant ventricular and atrial CM. This is based on cell isolation from cardiac tissue slices following repeated (usually overnight) storage of the tissue under conditions that prolong CM viability beyond the day of organ excision by two additional days. The maintenance of cells in their near-native microenvironment slows the otherwise rapid structural and functional decline seen in isolated CM during attempts for prolonged storage or culture. Multi-day slice-based CM isolation increases the amount of useful information gained per animal heart, improving reproducibility and reducing the number of experimental animals required in basic cardiac research. It also opens the doors to novel experimental designs, including exploring same-heart regional differences.